Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024530 (
malaria
)
44,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sporozoite forms of the Plasmodium parasite, the causative agent of
malaria
, are transmitted by mosquitoes and first infect the liver for an initial round of replication before parasite proliferation in the blood. The molecular mechanisms involved during sporozoite invasion of hepatocytes remain poorly understood. Two receptors of the Hepatitis C virus (HCV), the tetraspanin
CD81
and the scavenger receptor class B type 1 (SR-B1), play an important role during the entry of Plasmodium sporozoites into hepatocytes. In contrast to HCV entry, which requires both
CD81
and SR-B1 together with additional host factors,
CD81
and SR-B1 operate independently during
malaria
liver infection. Sporozoites from human-infecting P. falciparum and P. vivax rely respectively on
CD81
or SR-B1. Rodent-infecting P. berghei can use SR-B1 to infect host cells as an alternative pathway to
CD81
, providing a tractable model to investigate the role of SR-B1 during Plasmodium liver infection. Here we show that mouse SR-B1 is less functional as compared to human SR-B1 during P. berghei infection. We took advantage of this functional difference to investigate the structural determinants of SR-B1 required for infection. Using a structure-guided strategy and chimeric mouse/human SR-B1 constructs, we could map the functional region of human SR-B1 within apical loops, suggesting that this region of the protein may play a crucial role for interaction of sporozoite ligands with host cells and thus the very first step of
Plasmodium infection
.
...
PMID:Molecular determinants of SR-B1-dependent Plasmodium sporozoite entry into hepatocytes. 3278 57
<< Previous
1
2
3